Recent advances in the treatment of the acute hepatitis C
Palumbo, E.
Recenti Progressi in Medicina 98(4): 236-237
2007
ISSN/ISBN: 0034-1193 PMID: 17547361 Document Number: 612291
Acute hepatitis C is characterized by a frequent evolution in chronic form (70-85% of cases). The recent literature evidences that Peg-interferon alpha-2b is efficacy for the treatment of acute hepatitis C (90% of sustained response). Treatment, independently by HCV genotype and baseline viral load, must be prolonged for three months and it must be started into three months by onset.
Document emailed within 1 workday
Related Documents
Bailly, F.ço.; Hartig-Lavie, K.; Lebossé, F.; Pagès-Ecochard, M.; Zoulim, F. 2015: Treatment of hepatitis C: decisive therapeutic advances La Revue du Praticien 65(2): 255-256Little, J.W. 2000: Recent advances in the treatment of viral hepatitis General Dentistry 48(6): 672-9; quiz 680-1
Gupta, S.; Gupta, B.M.M. 2008: Acute pulmonary embolism advances in treatment Journal of the Association of Physicians of India 56: 185-191
Bernacer Borja, M.; Vecilla Rivelles, C.; Sánchez Fayos, J. 1983: Advances in the treatment of acute myeloblastic leukemias in children Anales Espanoles de Pediatria 19(Suppl 19): 65-69
Selidovkin, G.D.; Pushkareva, S.G.; Obukhova, E.E.; Melkova, K.N.; Gorbunova; Vorob'eva, S.V.; Davtian, A.A.; Danilova, N.B.; Konchalovskiĭ; Baranov, A.E. 1996: Advances and difficulties of present-day treatment of acute myeloblastic leukemia Gematologiia i Transfuziologiia 41(1): 6-9
Tian, D. 1982: Advances in the treatment of acute leukemia with homologous bone marrow transplantation Zhonghua Nei Ke Za Zhi 21(1): 55-57
Zeller, T. 2011: Advances in the treatment of acute thrombotic and chronic critical limb ischemia Journal of Cardiovascular Surgery 52(4): 459-460
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Lin, S.M.; Chu, C.M.; Shih, L.Y.; Liaw, Y.F. 1991: Hematological abnormalities in acute viral hepatitis and acute hepatitis in HBsAg carrier Changgeng Yi Xue Za Zhi 14(4): 253-258
Balwierz, W.; Moryl-Bujakowska, A.; Skoczeń, S.; Pawińska, K.; Balcerska, A.; Płoszyńska, A.; Chybicka, A.; Dobaczewski, G.; Juszczak, K.; Wachowiak, J.; Derwich, K.; Kowalczyk, J.; Wiśniewska-Slusarz, H.; Matysiak, Mł.; Krauze, A.; Rokicka-Milewska, R.; Pawelec, K.; Sońta-Jakimczyk, D.; Łuszczyńska, A.; Tomaszewska, R.; Wysocki, M.; Styczyński, J.; Swiatkiewicz, V. 2003: Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002 Przeglad lekarski 60 Suppl. 5: 13-16
Heldenberg, D.; Weizer, S. 1989: Acute type A hepatitis and acute glomerulonephritis in a carrier of hepatitis B antigen Harefuah 116(12): 637-638
Grangé, J-Didier. 2002: Treatment of acute hepatitis C Gastroenterologie Clinique et Biologique 26 Spec no 2: B32-B37
Mackenzie, D.L.; Gregory, D.H.; Vlahcevid, Z.R. 1975: Advances in viral hepatitis Virginia Medical Monthly 102(2): 125-132
Guardia, J. 1982: Advances in hepatitis--1981 Medicina Clinica 78(2): 67-68
Dumortier, J.; Slim, R.; Chevallier, M.; Boillot, O.; Thaunat, J.L.; Vaillant, E.; Vial, T.; Bellemin, B.; Paliard, P.; Scoazec, J.Y. 1999: Acute severe fibrosing hepatitis associated with ciprofibrate treatment Gastroenterologie Clinique et Biologique 23(12): 1399-1400
Ugriumov, B.L.; Frolov, A.F.; Gromashevskaia, L.L.; Vovk, A.D.; Tat'ianko, N.V. 1981: Corticosteroid treatment experience in acute viral hepatitis Klinicheskaia Meditsina 59(4): 63-67
Bravo, M.L.; Azagra, R.; Aguyé, A.; Freixas, M. 1992: Acute hepatitis: an adverse reaction to fenofibrate treatment Atencion Primaria 10(3): 697-698
Spelman, D. 1988: Infectious diseases. Recent advances in non-A non-B hepatitis Australian Family Physician 17(7): 553
Olfa, H.; Aroua, G.; Wissem, M.; Wafa, B.M.; Hichem, L.; Nabil, B.C.èn.; Fethia, B.; Leila, S. 2014: Fulminant acute hepatitis B after infliximab treatment in Crohn's disease La Tunisie Medicale 92(5): 349-350
Manciuc, C.; Vâţă, A.; Dorobăţ, C.; Scurtu, R.; Petrovici, C.; Luca, V. 2004: Lamivudine and alpha-IFN treatment of a severe case of acute hepatitis B Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 207-209